Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2008, 9(9), 1561-1594; doi:10.3390/ijms9091561
Review

Broad-Spectrum Drugs Against Viral Agents

 and
Received: 18 April 2008; Accepted: 29 August 2008 / Published: 1 September 2008
(This article belongs to the Special Issue Nucleic Acid Derivatives in Emerging Technologies)
View Full-Text   |   Download PDF [234 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: Development of antivirals has focused primarily on vaccines and on treatments for specific viral agents. Although effective, these approaches may be limited in situations where the etiologic agent is unknown or when the target virus has undergone mutation, recombination or reassortment. Augmentation of the innate immune response may be an effective alternative for disease amelioration. Nonspecific, broad-spectrum immune responses can be induced by double-stranded (ds)RNAs such as poly (ICLC), or oligonucleotides (ODNs) containing unmethylated deocycytidyl-deoxyguanosinyl (CpG) motifs. These may offer protection against various bacterial and viral pathogens regardless of their genetic makeup, zoonotic origin or drug resistance.
Keywords: CpG; cytokine; influenza; poly (ICLC); TLR CpG; cytokine; influenza; poly (ICLC); TLR
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Christopher, M.E.; Wong, J.P. Broad-Spectrum Drugs Against Viral Agents. Int. J. Mol. Sci. 2008, 9, 1561-1594.

AMA Style

Christopher ME, Wong JP. Broad-Spectrum Drugs Against Viral Agents. International Journal of Molecular Sciences. 2008; 9(9):1561-1594.

Chicago/Turabian Style

Christopher, Mary E.; Wong, Jonathan P. 2008. "Broad-Spectrum Drugs Against Viral Agents." Int. J. Mol. Sci. 9, no. 9: 1561-1594.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert